2023 Rheumatology Clinical Update: Pre-Course Activity

Current Status
Not Enrolled
Price
Closed
Get Started
This course is currently closed

This is the pre-course component of Rheumatology Clinical Update Course 2023. Participants of this course are REQUIRED to complete the pre-course activity before going to the face-to-face sessions.

 

ABOUT THE COURSE

This program aims to update practitioners in a wide variety of areas of Rheumatology relevant to general practice including: lupus, spondyloarthropathy, rheumatologic emergencies, and investigations. New additions include an approach to Fibromyalgia. Back by popular demand a physical exam and joint aspiration sessions. Updated session including COVID 19 vaccinations and treatment as well as medication management in the COVID19 patient with rheumatic disease. Registration is limited.

 

LEARNING OBJECTIVES

Upon completion of the course, participants will be equipped to:

  • Recognize rheumatologic emergencies and how to refer for appropriate care
  • Examine for and aspirate a knee effusion
  • Recognize inflammatory back pain on history
  • Identify mild and life threatening lupus manifestations
  • Identify what labs are useful in referring and monitoring Rheumatology patients
  • Review the COVID19 Vaccine and treatment guidelines for autoimmune disease patients
RESOURCES

Rheumatology Clinical Pathways

In this webpage, you may find information of enhanced clinical care pathways and telephone advice line developed through the Health Systems Support (HSS) group comprised of leadership from Alberta Health Services and Calgary area Primary Care Networks combined with specialists. Scroll down to the last section for Rheumatology clinical pathways.

(placeholder for more resources)

TO NAVIGATE THROUGH THE ONLINE MODULES
  • It is not recommended to access the online modules on smartphones at this point as your learning experience might be compromised.
  • There are required learning activities in the modules, such as reviewing text and video materials. Handouts are available for you to download.
  • ‘TAKE NOTES’: To make notes for your own use, click on ‘TAKE NOTES’ at the upper right corner of your screen to open the notes field. All the course notes you have made can be found in a full list in the page of ‘My Courses’.
  • ‘RESUME LEARNING”: For the convenience of self-paced learning, you may exit from the middle of the course and come back later. When you log into the e-learning portal again, click on ‘RESUME LEARNING’, and you will be redirected to where you left last time.
ADDITIONAL INFORMATION
  • This course has received no commercial sponsorship support.
  • This course was planned to achieve scientific integrity, objectivity and balance.
  • Planning Committee disclosure:

Planning Committee Members

Credential

Disclosure

Affiliation

Steven Thomson (Chair)

MD, MSc

Speaker Funding: Abbvie; Educational Steering Committee: Jansen

Ad Boards: Pfizer, BMS, Jansen, UCB (2020), Novartis, Lily

Rheumatologist

Clinical Assistant Professor

Department of Medicine,

University of Calgary

Alexandra Charlton

BScPharm, ACPR, PharmD

Nothing to disclose

Pharmacy Clinical Practice Leader, Rockyview

Pharmacist, Rheumatology RRDTC

Cathryn Kuzyk

MD, CCFP

Nothing to disclose

 

Eric James Campbell

MD FRCPC

Honoraria: Abbvie, Novartis

Advisory Board: Novartis

Clinical Assistant Professor, University of Calgary

Rheumatologist

Stephanie Garner

MD, FRCPC

Advisory Board: Abbvie, Amgen, UCB, Pfizer and Novartis

Clinical Assistant Professor, University of Calgary, Rheumatologist, South Health Campus

Stuart Wiber

MD, FRCPC

Nothing to disclose

Clinical Lecturer, Rheumatologist, University of Calgary

Mylan Doan-Nguyen

EdD

University of Calgary Employee

U of C, Cumming School of Medicine, CME&PD Office

 

  • Faculty disclosure:

Faculty

Credentials

Disclosure

Affiliation

Alexandra (Ola) Kobza

MD

Nothing to disclose

Resident physician – 4th year Rheumatology fellow, University of Calgary

Eugene Krustev

MD

Investments in health organizations: Mountain Valley MD Holdings Inc, Intercept Pharmaceuticals, Chemocentryx Pharmaceuticals and Gilead Sciences.

PGY-4 Rheumatology Fellow, University of Calgary

Hengameh Kheirkhah

MD

Nothing to disclose

Resident physician, Rheumatology Fellow, University of Calgary

Megan Barber

MD, FRCPC, PhD

Advisory boards: GSK, Janssen, AstraZeneca, Sanofi-Genzyme, AbbVie

Funded grants and clinical trials: MSI foundation, Amgen, UCB

Clinical Assistant Professor, University of Calgary; Rheumatologist

Stephanie Garner

MD FRCPC

Advisory Board: Abbvie, Amgen, UCB, Pfizer and Novartis

Clinical Assistant Professor, University of Calgary; Rheumatologist, South Health Campus

Stuart Wiber

MD FRCPC

Speaker honorarium – Continuing Medical Education

Advisory boards:  Sanofi, Janssen, Novartis, Abbvie, Roche, Bristol Myers Squibb

Clinical Lecturer, Rheumatologist, University of Calgary

 

Steven Thomson MD MSc (Chair)
Alexandra Charlton BScPharm ACPR PharmD 
Cathryn Kuzyk MD CCFP
Eric James Campbell MD FRCPC 
Stephanie Garner MD FRCPC 
Stuart Wiber MD FRCPC
Mylan Doan-Nguyen EdD (CME Representative)

Material presented are in compliance with the University of Calgary Copyright Policy, Acceptable Use of Material Protected by Copyright.

Course materials are for individual use only and not to be distributed.